Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta- 211At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing

Associate Professor Kazuharu Arakawa and Project Assistant Professor Nobuaki Kono of IAB in collaboration with Quantum Beam Science Research Directorate, National Institutes for Quantum and Radiological Science and Technology, published the findings of a new study entitled " Anti-tumor effects and potential therapeutic response biomarkers in α-emitting meta -²¹¹At-astato-benzylguanidine therapy for malignant pheochromocytoma explored by RNA-sequencing" in Theranostics on February 27, 2019.

LINK